Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

MIP Discovery positive progress update

8 Feb 2023 07:00

RNS Number : 2111P
Mercia Asset Management PLC
08 February 2023
Β 

RNS Reach

8 February 2023

Β 

Mercia Asset Management PLC

Β 

("Mercia", the "Group" or the "Company")

Β 

MIP Discovery positive progress update

Β 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.Β£1.4billion of assets under management,Β is pleased to share positive developments at MIP Discovery Limited ("MIP"), one of its direct investments.

Β 

MIP has recently announced that it has secured significant grant funding from the Bill & Melinda Gates Foundation. The funding will support a project focused on the use of MIP's detection reagents, to enable low-cost, high-volume diagnostic tests for low and middle-income countries, during endemic or pandemic outbreaks.

Β 

In parallel, MIP has announced the appointment of Brian Burke to its board as Chief Commercial Officer, bringing extensive experience from his tenure as Global Head of Strategy and Corporate Development at Horizon Discovery.

Β 

A Leicester University spinout, MIP was originally supported via Mercia's third-party managed funds. It is a nanotechnology business that has developed and patented a novel design and development process to make nano-scale molecularly imprinted polymers ("nanoMIPs"), that act as stable and highly cost-effective synthetic antibodies which require no animal testing and have a multitude of industrial applications. In addition to holding 20.1% via its managed funds, Mercia holds a fully diluted direct investment stake in MIP of 10.2%.

Β 

Dr Mark Payton, CEO of Mercia Asset Management PLC and non-executive Director on the MIP board commented: "We are excited by the continued progress being seen at MIP. Attracting funding from the Bill & Melinda Gates Foundation is testament to the significant potential of MIP's platform technology to solve critical diagnostic challenges and deliver solutions that meaningfully improve healthcare outcomes, in the parts of the world that most need help. Brian's appointment also strengthens its executive team and will bring valuable commercial expertise, as MIP takes specific products in development toward material market opportunities."

Β 

Β 

Β -Ends-

Β 

For further information, please contact:

Β 

Mercia Asset Management PLC

MarkΒ Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

Β 

+44 (0)330 223 1430

Β 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

+44 (0)20 3727 1051

Tom Blackwell, Immy Ransom

mercia@fticonsulting.com

Β 

About Mercia Asset Management PLC

Β 

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

Β 

The Group has a strongΒ UKΒ footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

Β 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAUPURPPUPWGAM
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNS-RDirect investment portfolio cash receipts update
11th May 20267:00 amRNSTransfer of Treasury Shares
7th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSWarwick Acoustics Update
23rd Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20262:42 pmRNSTransfer of Treasury Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSYear end trading summary and notice of FY results
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSDirector/PDMR Dealings
7th Apr 20267:00 amRNSTransfer of Treasury Shares
1st Apr 20267:00 amRNSShare Buyback Programme
31st Mar 20265:00 pmRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSMercia's Northern VCTs raise record £80.0million
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSDirect investment Tozaro raises £6.0million
13th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.